T4 ENDONUCLEASE V--STRUCTURE/FUNCTION ANALYSES
T4 核酸内切酶 V--结构/功能分析
基本信息
- 批准号:2153558
- 负责人:
- 金额:$ 22.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-07-01 至 2000-09-29
- 项目状态:已结题
- 来源:
- 关键词:DNA repair N glycosidase X ray crystallography active sites chemical binding chemical cleavage chemical kinetics computer simulation conformation crosslink endonuclease enzyme mechanism enzyme structure enzyme substrate enzyme substrate complex fluorescent dye /probe molecular cloning mutant nuclear magnetic resonance spectroscopy nucleic acid structure protein sequence pyrimidine dimers scanning electron microscopy site directed mutagenesis transmission electron microscopy
项目摘要
There is a well established link between inefficient DNA repair of
ultraviolet (UV) light induced damage and carcinogenesis in man, as
demonstrated through the study of the human disease, xeroderma pigmentosum
and epidemiological studies of nonmelanoma skin cancer. Enhanced UV
exposure and persistence of dipyrimidine photoproducts have been correlated
with oncogene activation and tumor suppressor inactivation . Thus, the
ability to maintain DNA integrity is rooted in accurate DNA repair systems
that catalyze the restoration of damaged DNAs to their native state as well
as high fidelity DNA replication. The variety of ubiquitous DNA repair
pathways include recombinational, nucleotide, and base excision repair. The
initial steps of the base excision pathway consist of the location,
recognition, and release of damaged bases by DNA glycosylases. These
enzymes sometimes have a concomitant AP lyase activity. One of these
enzymes, T4 endonuclease V, is a cyclobutane pyrimidine dimer DNA
glycosylase-AP lyase. Previous studies have revealed the fundamental
mechanisms by which this enzyme initiates repair at this UV-induced lesion,
and include the determination of its active site, the sequences that are
responsible for DNA binding and the chemical basis for catalysis. In order
for endonuclease V to continue to serve as the prototype for mechanistic
studies of this class of enzymes, the following specific aims are proposed:
1) Develop fine structure kinetic analyses of endonuclease V-catalyzed
reactions. order to determine the progression of steps that ultimately lead
to enzyme-mediated catalysis, a full kinetic heme will be developed using
rapid quench-flow technologies and novel DNA substrates. 2) Determine the
molecular architecture of endonuclease V bound to cyclobutane
dimer.containing DNA. It is hypothesized that endonuclease V undergoes a
conformational change on dimer-specific binding. This hypothesis will be
tested by biophysically characterizing DNA-protein completes before and
after the glycosylase step. 3) Describe the architecture of endonuclease
V-nontarget DNA interactions and determine the mechanism of target site
location. A variety of genetic and biophysical methods will be used to
investigate hypotheses concerning the associations between nontarget DNA
and endonuclease V. 4) Determine the analytic mechanisms for other
pyrimidine dimer-specific DNA glycosylases-AP lyases. It is hypothesized
that all DNA glycosylases-AP lyases function through a common chemistry.
This will be tested by elucidating the catalytic mechanism of action for
other dimer-specific DNA glycosylase-AP lyases. These studies may the
foundation for developing unifying principles for initiating the
restoration of damaged DNA by DNA glycosylases. In the long term, this will
involve the following determinations: 1) what are the mechanisms by se
proteins locate sites of specific damage within vast excesses of undamaged
DNA; 2) what are the principles for specific substrate recognition and what
are the structural motifs within these proteins that achieve differential
binding; 3) what are the active site residues within these enzymes and how
do these residues suggest catalytic mechanisms; 4 what is the chemical
basis for glycosyl bond cleavage?
在效率低下的DNA修复之间存在良好的联系
紫外线(UV)的光引起人类的损害和致癌作用,因为
通过研究人类疾病的研究证明
非甲状腺瘤皮肤癌的流行病学研究。增强的紫外线
二吡二酰亚胺光产物的暴露和持久性已相关
癌基因激活和肿瘤抑制灭活。因此,
保持DNA完整性的能力植根于精确的DNA修复系统
这也将损坏的DNA恢复到其祖国状态
作为高保真DNA复制。多种无处不在的DNA修复
途径包括重组,核苷酸和碱基切除修复。这
基本切除途径的初始步骤由位置组成,
DNA糖基酶识别并释放受损碱。这些
酶有时具有伴随的AP溶酶活性。其中之一
酶,T4核酸内切酶V,是环丁烷嘧啶二聚体DNA
糖基酶-ap裂解酶。先前的研究表明了基本
该酶在此紫外线诱导的病变处启动修复的机制,
并包括确定其活性位点的确定
负责DNA结合和催化的化学基础。为了
核酸内切酶V继续充当机械的原型
对这类酶的研究,提出了以下特定目的:
1)开发核酸内切酶V催化的精细结构动力学分析
反应。为了确定最终领导的步骤的进展
为了酶介导的催化,将开发完整的动力学血红素
快速淬灭流技术和新型DNA底物。 2)确定
核酸内切酶V与环丁烷结合的分子结构
二聚体。假设核酸内切酶V发生A
二聚体特异性结合的构象变化。这个假设将是
通过生物物理表征DNA-蛋白质的测试
糖基酶步骤之后。 3)描述核酸内切酶的结构
V-nontarget DNA相互作用并确定目标位点的机理
地点。多种遗传和生物物理方法将用于
研究有关非目标DNA之间关联的假设
4)确定其他其他的分析机制
嘧啶二聚体特异性DNA糖基酶-AP裂解酶。它是假设的
所有DNA糖基酶-AP裂解酶通过常见的化学作用。
这将通过阐明作用的催化机理来测试
其他二聚体特异性的DNA糖基酶-AP裂解酶。这些研究可能是
制定统一原则的基础
通过DNA糖基酶恢复受损的DNA。从长远来看,这将
涉及以下确定:1)SE的机制是什么
蛋白质在巨大过度损坏的地方找到特定损害的部位
脱氧核糖核酸; 2)特定底物识别的原则是什么?
是这些蛋白质中的结构基序
结合; 3)这些酶中的活性位点残基是什么?
这些残基是否提示催化机制? 4什么是化学物质
糖基键裂解的基础?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R. Stephen Lloyd其他文献
Site-directed mutagenesis of the T4 endonuclease V gene: role of lysine-130.
T4 核酸内切酶 V 基因的定点诱变:赖氨酸 130 的作用。
- DOI:
10.1021/bi00406a006 - 发表时间:
1988 - 期刊:
- 影响因子:2.9
- 作者:
Adrian Recinos;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
Site-directed mutagenesis of the T4 endonuclease V gene: role of tyrosine-129 and -131 in pyrimidine dimer-specific binding.
T4 核酸内切酶 V 基因的定点诱变:酪氨酸 129 和 -131 在嘧啶二聚体特异性结合中的作用。
- DOI:
10.1021/bi00406a007 - 发表时间:
1988 - 期刊:
- 影响因子:2.9
- 作者:
Donald G. Stump;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
Mutagenic bypass of the butadiene-derived 2′-deoxyuridine adducts by polymerases η and ζ
- DOI:
10.1016/j.mrfmmm.2007.05.003 - 发表时间:
2007-12-01 - 期刊:
- 影响因子:
- 作者:
Priscilla H. Fernandes;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
R. Stephen Lloyd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R. Stephen Lloyd', 18)}}的其他基金
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
碱基切除修复在限制肝细胞癌中的作用
- 批准号:
10292967 - 财政年份:2020
- 资助金额:
$ 22.15万 - 项目类别:
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas -Administrative Supplement
碱基切除修复在限制肝细胞癌中的作用 - 行政补充
- 批准号:
10378947 - 财政年份:2020
- 资助金额:
$ 22.15万 - 项目类别:
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
碱基切除修复在限制肝细胞癌中的作用
- 批准号:
10513822 - 财政年份:2020
- 资助金额:
$ 22.15万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
7728334 - 财政年份:2009
- 资助金额:
$ 22.15万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8098171 - 财政年份:2009
- 资助金额:
$ 22.15万 - 项目类别:
T4 Endonuclease V Structure-Function Analysis
T4 核酸内切酶 V 结构功能分析
- 批准号:
7911342 - 财政年份:2009
- 资助金额:
$ 22.15万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8453441 - 财政年份:2009
- 资助金额:
$ 22.15万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8249438 - 财政年份:2009
- 资助金额:
$ 22.15万 - 项目类别:
相似国自然基金
特定聚合度区间几丁寡糖用新型β-N-乙酰氨基己糖苷酶的发掘、分子改造及作用机制
- 批准号:22308258
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
N-乙酰氨基葡萄糖苷酶CmNAGase合成几丁寡糖的机制及其理性改造
- 批准号:22278220
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
高效合成乳糖-N-新四糖用糖苷酶的发掘、分子改造、性质及反应机制
- 批准号:32172159
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
家蚕β-1, 4-N-乙酰葡萄糖胺糖苷酶1基因(BmGlcNase1) 调控茧丝产量的分子机制研究
- 批准号:31902211
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
化学蛋白质组学技术在血型改造糖苷酶筛选中的应用
- 批准号:21807106
- 批准年份:2018
- 资助金额:27.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular Pharmacology of Tumor and Virus Inhibitors
肿瘤和病毒抑制剂的分子药理学
- 批准号:
6894590 - 财政年份:2004
- 资助金额:
$ 22.15万 - 项目类别:
Mutagenic and Repair Mechanisms of Endogenous DNA Damage
内源性DNA损伤的诱变与修复机制
- 批准号:
6990324 - 财政年份:2004
- 资助金额:
$ 22.15万 - 项目类别:
Structure and Mechanism of Base-Excision DNA Repair
碱基切除DNA修复的结构和机制
- 批准号:
7021419 - 财政年份:2003
- 资助金额:
$ 22.15万 - 项目类别:
Structure and Mechanism of Base-Excision DNA Repair
碱基切除DNA修复的结构和机制
- 批准号:
6712756 - 财政年份:2003
- 资助金额:
$ 22.15万 - 项目类别:
Structure and Mechanism of Base-Excision DNA Repair
碱基切除DNA修复的结构和机制
- 批准号:
6858578 - 财政年份:2003
- 资助金额:
$ 22.15万 - 项目类别: